News
HHS To Require Placebo-Controlled Trials for All New Vaccines in ‘Radical Departure’ From Past
The new policy, revealed by the Department of Health and Human Services on Wednesday, would make vaccines “less available and less affordable,” according to vaccine expert Paul Offit. It could also further complicate the picture for companies like Novavax.
The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...
The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...
Scripps News on MSN1d
HHS, NIH announce development of universal vaccine for COVID-19 and influenzaResearchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...
While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...
The U.S. Department of Health and Human Services and the National Institutes of Health made an announcement of the latest ...
HHS implemented a pause on research of deadly infectious diseases at one of the nation's most highly secure research labs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback